Novo Nordisk Shares Plunge on Insulin's FDA Failure

Feb. 11 (Bloomberg) -- Bloomberg's Caroline Hyde reports that Novo Nordisk shares have fallen the most in a decade as the company's new insulin drug Tresiba has failed to win FDA approval in the United States. She speaks on Bloomberg Television's "The Pulse."
2016 Chevrolet Malibu Unveiled at New York Auto Show
12:41 - Alan Batey, head of General Motors Co.'s North American operations and Chevrolet brand, unveils the redesigned 2016 Chevrolet Malibu mid-sized sedan at the New York International Auto Show. (Video courtesy of General Motors. Source: Bloomberg)
  • Audi U.S. Chief Keogh Says March Sales Surged 20%
  • ADP Jobs Report Falls Short of Expectations at 189K
  • Here Comes a New Wave of Billion-Dollar Hedge Funds